Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblasts
- 31 March 2009
- journal article
- Published by Springer Nature in Amino Acids
- Vol. 38 (3) , 763-769
Abstract
Preptin, a newly isolated 34-amino-acid peptide hormone that is cosecreted with insulin and amylin from pancreatic beta-cells, has emerged as a regulatory element in bone metabolism, but its mechanism remains unclear. We assessed the effects of preptin on proliferation and differentiation of human osteoblasts and investigated the mechanism involved. Our results demonstrated that preptin promoted human osteoblasts proliferation and alkaline phosphatase activity. Suppression of connective tissue growth factor (CTGF), which was upregulated by preptin in a dose- and time-dependent manner, with small interfering RNA (siRNA) abolished the preptin-induced human osteoblasts proliferation and differentiation. Preptin induced activation of ERK mitogen-activated protein kinase (MAPK), but not p38 or JNK in human osteoblasts. Furthermore, pretreatment of human osteoblasts with the ERK inhibitor PD98059 abolished the preptin-induced CTGF secretion and blocked the promoting effect of preptin on osteoblasts proliferation and differentiation. These data demonstrated that preptin is involved in bone anabolism mediated by ERK/CTGF in human osteoblasts and may contribute to the preservation of bone mass observed in hyperinsulinemic states, such as obesity.Keywords
This publication has 23 references indexed in Scilit:
- Preptin, another peptide product of the pancreatic β-cell, is osteogenic in vitro and in vivoAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF‐β1‐induced extracellular matrix production in osteoblastsJournal of Cellular Physiology, 2006
- Effect of Weight Loss on Bone Metabolism: Comparison of Vertical Banded Gastroplasty and Medical InterventionObesity Surgery, 2003
- Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet β-cells and enhances insulin secretionBiochemical Journal, 2001
- Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male miceAmerican Journal of Physiology-Endocrinology and Metabolism, 1998
- Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.Journal of Clinical Investigation, 1998
- Insulin increases histomorphometric indices of bone formation In vivoCalcified Tissue International, 1996
- A multicenter study of the influence of fat and lean mass on bone mineral content: evidence for differences in their relative influence at major fracture sites. Early Postmenopausal Intervention Cohort (EPIC) Study GroupThe American Journal of Clinical Nutrition, 1996
- Amylin Stimulates Osteoblast Proliferation and Increases Mineralized Bone Volume in Adult MiceBiochemical and Biophysical Research Communications, 1995
- Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.Proceedings of the National Academy of Sciences, 1987